mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
Time：
2026-09-14 09:04
Author：
xieyijun
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
Time：
2026-09-12 08:55
Author：
xieyijun
Novartis has failed, but Lp(a) has not yet
Time：
2026-09-11 08:29
Author：
xieyijun
Why is Biotech taking over Pfizer's ADC "abandoned child"?
Time：
2026-09-10 08:02
Author：
xieyijun
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
Time：
2026-09-08 08:08
Author：
xieyijun
The rise of self-immune big products
Time：
2026-09-07 08:11
Author：
xieyijun
When Biotech starts making money
Innovation Medicine Mid term Exam 2026
Time：
2026-09-06 10:29
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务